Over 50% of CT contrast enhanced power injected procedures are ordered for the abdomen/pelvis region1.
P3T® Abdomen supports the imaging of the liver, pancreas, and kidneys.
Two key factors controlling enhancement of liver parenchyma2
| 1. Body weight - this is the main factor |
2. Iodine concentration of contrast media |
 |
 |
Extensive clinical research supports weight-based contrast dosing for abdominal imaging. Three primary rationales for weight-based dosing include patient safety3, consistent image quality4, and potentially reduced contrast5,3.
-Patient weight 120 lbs. -Contrast Concentration 350
(Click images above for larger version)
The P3T® Abdomen application automatically adjusts contrast volume based on systematic scientific methods, according to patient, procedure, and prescribed physician parameters.
| References: |
|
|
1. Reference on file
2. Optimal Vascular and Parenchymal Contrast Enhancement: The Current State of the Art. Radiology Clinic of North America. 2009 Dominik Fleishchmann, MD, Aya Kamaya, MD.
3. Brink J, et al. Hepatic Spiral CT: Reduction of Dose of Intravenous Contrast Material. Radiology 1995: 197:83-88. |
4. Yanaga, Y. et al, Pancreas Body Weight-tailored Contrast Material Injection Protocol versus Fixed Dose Protocol at Dynamic CT. Radiology 2007; 245: 475-487.
5. Megibow, et al. Quantitative and Qualitative Evaluation of Low Osmolality Contrast Medium Needed for routine Helical Abdominal CT. AJR 2001: 176:538-589. |